Itaconate in host inflammation and defense
Immune cells undergo rapid and extensive metabolic changes during inflammation. In
addition to contributing to energetic and biosynthetic demands, metabolites can also …
addition to contributing to energetic and biosynthetic demands, metabolites can also …
NRF2-mediated regulation of lipid pathways in viral infection
K Muzammil, ZS Ghnim, IS Gataa… - Molecular Aspects of …, 2024 - Elsevier
The first line of defense against viral infection of the host cell is the cellular lipid membrane,
which is also a crucial first site of contact for viruses. Lipids may sometimes be used as viral …
which is also a crucial first site of contact for viruses. Lipids may sometimes be used as viral …
[HTML][HTML] Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
N Kurmasheva, A Said, B Wong, P Kinderman… - Nature …, 2024 - nature.com
The presence of heterogeneity in responses to oncolytic virotherapy poses a barrier to
clinical effectiveness, as resistance to this treatment can occur through the inhibition of viral …
clinical effectiveness, as resistance to this treatment can occur through the inhibition of viral …
[HTML][HTML] Itaconate inhibits SYK through alkylation and suppresses inflammation against hvKP induced intestinal dysbiosis
Y Li, Y Xu, W Li, J Li, W Wu, J Kang, H Jiang… - Cellular and Molecular …, 2023 - Springer
Hypervirulent Klebsiella pneumoniae (hvKP) is a highly lethal opportunistic pathogen that
elicits more severe inflammatory responses compared to classical Klebsiella pneumoniae …
elicits more severe inflammatory responses compared to classical Klebsiella pneumoniae …
4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1
In recent years, especially since the outbreak of the severe acute respiratory syndrome
coronavirus 2 pandemic, the cell-permeable itaconate derivative 4-octyl itaconate (4-OI) has …
coronavirus 2 pandemic, the cell-permeable itaconate derivative 4-octyl itaconate (4-OI) has …
[HTML][HTML] Targeting mitochondrial metabolites and nucleic acids as an anti-inflammatory strategy
Y Min, LAJ O'Neill - Frontiers in Drug Discovery, 2023 - frontiersin.org
Mitochondrial metabolites and their derivatives have been the focus of recent efforts to
develop new anti-inflammatory therapeutics. The widely used therapeutic agents dimethyl …
develop new anti-inflammatory therapeutics. The widely used therapeutic agents dimethyl …
[HTML][HTML] Metabolomics combined with network pharmacology reveals a role for astragaloside IV in inhibiting enterovirus 71 replication via PI3K-AKT signaling
JF Hao, X Zhang, R Hu, X Lu, H Wang, Y Li… - Journal of Translational …, 2024 - Springer
Abstract Background Astragaloside IV (AST-IV), as an effective active ingredient of
Astragalus membranaceus (Fisch.) Bunge. It has been found that AST-IV inhibits the …
Astragalus membranaceus (Fisch.) Bunge. It has been found that AST-IV inhibits the …
[HTML][HTML] Lanatoside C inhibits herpes simplex virus 1 replication by regulating NRF2 distribution within cells
S Wu, S Wang, X Lin, S Yang, X Ba, D Xiong, L Xiao… - Phytomedicine, 2024 - Elsevier
Background In the past decades, extensive research has been conducted to identify new
drug targets for the treatment of Herpes simplex virus type 1 (HSV-1) infections. However …
drug targets for the treatment of Herpes simplex virus type 1 (HSV-1) infections. However …
Sulforaphane improves redox homeostasis and right ventricular contractility in a model of pulmonary hypertension
A Conzatti, R Colombo, R Siqueira… - Journal of …, 2022 - journals.lww.com
Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary vascular
resistance, imposing overload on the right ventricle (RV) and imbalance of redox state. Our …
resistance, imposing overload on the right ventricle (RV) and imbalance of redox state. Our …